ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,187.70
0.13%
US Tech 100
17,622.40
0.05%
다우존스 지수
38,884.26
0.08%
Bitcoin
62,330.30
-0.01%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Cellectis SA (CLLS)

  7. Cellectis SA (CLLS) 뉴스

CLLS Cellectis SA

2.97
-0.13 (-4.19%)
시간외 단일가
최종 업데이트: 18:49:49
15분 지연
기업명 주식 심볼 시장 주식 타입
Cellectis SA CLLS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.13 -4.19% 2.97 18:49:49
개장가 저가 고가 종가 전일 종가
3.10
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
06/05/202419:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/05/202415:00GLOBECellectis Announces Completion of the Additional Equity..
03/05/202405:30GLOBECellectis Appoints Arthur Stril as Interim Chief Financial..
30/04/202405:46GLOBECellectis Reports Financial Results for the Fourth Quarter..
23/04/202405:30GLOBECellectis Presents Novel TALEN® Editing Processes Enabling..
11/04/202405:30GLOBECellectis Publishes a Novel Intronic Gene Editing Approach..
09/04/202405:30GLOBECellectis Announces Two Poster Presentations on Novel TALEN®..
17/01/202406:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/01/202406:30GLOBECellectis announces the drawdown of the second tranche of..
23/12/202306:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/12/202306:30GLOBECellectis Reports Results from Shareholders Meeting Held on..
23/12/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/11/202306:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/11/202306:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/11/202306:30GLOBECellectis’ Shareholders Meeting to be Held on December 22,..
15/11/202321:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202316:30GLOBECellectis Announces the execution of the Subsequent..
10/11/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202306:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202306:30GLOBECellectis Reports Financial Results for Third Quarter and..
03/11/202305:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202305:30GLOBECellectis to Present Preliminary Results of NATHALI_01 and..
02/11/202305:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202305:30GLOBECellectis to Report Third Quarter 2023 Financial Results on..
02/11/202304:15APSBiotech Shares Soar After AstraZeneca Stake & Research..
01/11/202320:52DJNCellectis Shares Soar Premarket on AstraZeneca Deal
01/11/202320:51DJNCellectis Shares Soar Premarket on AstraZeneca Deal
01/11/202319:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202317:17DJNAstraZeneca to Invest $245 Million in Deal With Cellectis
01/11/202316:00GLOBECellectis Announces Strategic Collaboration and Investment..
01/11/202306:10EDGAR2Form 20-F/A - Annual and transition report of foreign..
01/11/202306:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202305:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202305:30GLOBECellectis Presents Pre-Clinical Data on Multi-armored..
25/10/202305:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/10/202305:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/10/202305:30GLOBECellectis and Imagine Institute Publish A Proof-Of-Concept..
28/09/202305:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/09/202305:30GLOBECellectis to Present Pre-Clinical Data on Multi-armored..
06/09/202305:32EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
08/08/202306:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/08/202305:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/08/202305:30GLOBECellectis Provides Full Report for Second Quarter 2023..
08/08/202305:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/08/202305:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/08/202305:30GLOBECellectis Provides Business Updates and Preliminary..
28/07/202305:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/07/202305:30GLOBECellectis to Report Second Quarter 2023 Financial Results on..

최근 히스토리

NASDAQ
CLLS
Cellectis
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유